Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial

Authors: Pellegrino, B. ^{1, 2, †}, Capoluongo, E.D. ^{3, 4, †}, Bagnoli, M. ⁵, Arenare, L. ⁶, Califano, D. ⁷, Scambia, G. ^{8, 9}, Cecere, S.C. ¹⁰, Silini, E.M. ¹¹, Scaglione, G.L. ¹², Spina, A. ⁷, Tognon, G. ¹³, Campanini, N. ¹¹, Pisano, C. ¹⁰, Russo, D. ⁷, Pettinato, A. ¹⁴, Scollo, P. ¹⁵, Iemmolo, R. ¹⁶, De Cecco, L. ⁵, Musolino, A. ^{1, 2, 17}, Marchini, S. ¹⁸, Beltrame, L. ¹⁸, Paracchini, L. ¹⁸, Perrone, F. ⁶, Mezzanzanica, D. ^{5, ‡}, Pignata, S. ^{10, ‡, ∗}

Source: In ESMO Open January 2025 10(1)

Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients

Authors: Gravina, A. ¹, Gargiulo, P. ¹, De Laurentiis, M. ², Arenare, L. ¹, De Placido, S. ³, Orditura, M. ⁴, Cinieri, S. ⁵, Riccardi, F. ⁶, Ribecco, A.S. ⁷, Putzu, C. ⁸, Del Mastro, L. ^{9, 10}, Rossi, E. ¹¹, Ciardiello, F. ⁴, Di Rella, F. ², Nuzzo, F. ², Pacilio, C. ², Caputo, R. ², Cianniello, D. ², Forestieri, V. ³, Giuliano, M. ³, Arpino, G. ³, Orlando, L. ⁵, Mocerino, C. ⁶, Schettino, C. ¹, Piccirillo, M.C. ¹, Gallo, C. ¹², Perrone, F. ^{1, ∗}

Source: In ESMO Open January 2025 10(1)

Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology

Authors: Paratore, C. ^{1, †}, Zichi, C. ^{2, †}, Schiavone, R. ³, Caglio, A. ², Gamba, T. ², Bombaci, S. ¹, Vellani, G. ¹, Marandino, L. ⁴, Perrone, F. ⁵, Di Maio, M. ^{3, ∗}

Source: In ESMO Open August 2024 9(8)

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy

Authors: Pignata, S., Califano, D., Lorusso, D., Arenare, L., Bartoletti, M., De Giorgi, U., Andreetta, C., Pisano, C., Scambia, G., Lombardi, D., Farolfi, A., Cinieri, S., Passarelli, A., Salutari, V., De Angelis, C., Mignogna, C., Priolo, D., Capoluongo, E.D., Tamberi, S., Scaglione, G.L., Arcangeli, V., De Cecio, R., Scognamiglio, G., Greco, F., Spina, A., Turinetto, M., Russo, D., Carbone, V., Casartelli, C., Schettino, C., Perrone, F.

Source: In Annals of Oncology July 2024 35(7):667-676

ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer

Authors: Carrera, P.M., Curigliano, G., Santini, D., Sharp, L., Chan, R.J., Pisu, M., Perrone, F., Karjalainen, S., Numico, G., Cherny, N., Winkler, E., Amador, M.L., Fitch, M., Lawler, M., Meunier, F., Khera, N., Pentheroudakis, G., Trapani, D., Ripamonti, C.I.

Source: In ESMO Open May 2024 9(5)

Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials

Authors: Arenare, L., Di Liello, R., De Placido, P., Gridelli, C., Morabito, A., Pignata, S., Nuzzo, F., Avallone, A., Maiello, E., Gargiulo, P., Schettino, C., Gravina, A., Gallo, C., Chiodini, P., Di Maio, M., Perrone, F., Piccirillo, M.C.

Source: In ESMO Open March 2024 9(3)

Introduction to this special section: Full-waveform inversion

Authors: Perrone, F., Grobbe, N.

Source: Leading edge. 42(3):152-155

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631571849&indx=1&recIds=ETOCRN631571849

Lymph-vascular Space Involvement and/or p53 Overexpression Correlated With the Clinical Outcome of Early-stage Endometrial Cancer Patients Treated With Adjuvant Vaginal Brachytherapy

Authors: Laliscia, C., Gadducci, A., Coccia, N., Mattioni, R., Fuentes, T., Caretto, M., Pistolesi, S., Puccini, P., Perrone, F., Morganti, R.

Source: Anticancer research. 43(1):149-156

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN630784712&indx=1&recIds=ETOCRN630784712

Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients

Authors: Arenare, L., Porta, C., Barberio, D., Terzolo, S., Zagonel, V., Pisconti, S., Del Mastro, L., Pinto, C., Bilancia, D., Cinieri, S., Rizzo, M., Migliaccio, G., Montesarchio, V., Del Campo, L., De Lorenzo, F., Iannelli, E., Traclò, F., Gitto, L., Vaccaro, M.C., Frontini, L., Giannarelli, D., Bryce, J., Piccirillo, M.C., Jommi, C., Efficace, F., Riva, S., Di Maio, M., Gallo, C., Perrone, F.

Source: In ESMO Open December 2023 8(6)

ESMO Guidance for Reporting Oncology real-World evidence (GROW)

Authors: Castelo-Branco, L., Pellat, A., Martins-Branco, D., Valachis, A., Derksen, J.W.G., Suijkerbuijk, K.P.M., Dafni, U., Dellaporta, T., Vogel, A., Prelaj, A., Groenwold, R.H.H., Martins, H., Stahel, R., Bliss, J., Kather, J., Ribelles, N., Perrone, F., Hall, P.S., Dienstmann, R., Booth, C.M., Pentheroudakis, G., Delaloge, S., Koopman, M.

Source: In Annals of Oncology December 2023 34(12):1097-1112

Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology

Authors: Leone, A.G., Miceli, R., Trapani, D., Massagrande, M., Morano, F., Marsoni, S., La Verde, N., Berardi, R., Casolino, R., Lambertini, M., Dalu, D., Di Maio, M., Beretta, G.D., Perrone, F., Cinieri, S., Pietrantonio, F.

Source: In ESMO Open June 2023 8(3)

Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review

Authors: Miglietta, F., Fabi, A., Generali, D., Dieci, M.V., Arpino, G., Bianchini, G., Cinieri, S., Conte, P.F., Curigliano, G., De Laurentiis, M., Del Mastro, L., De Placido, S., Gennari, A., Puglisi, F., Zambelli, A., Perrone, F., Guarneri, V.

Source: In Cancer Treatment Reviews March 2023 114

Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020

Authors: Paratore, C., Zichi, C., Audisio, M., Bungaro, M., Caglio, A., Di Liello, R., Gamba, T., Gargiulo, P., Mariniello, A., Reale, M.L., Perrone, F., Di Maio, M.

Source: In ESMO Open December 2022 7(6)

Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial

Authors: Capoluongo, E.D., Pellegrino, B., Arenare, L., Califano, D., Scambia, G., Beltrame, L., Serra, V., Scaglione, G.L., Spina, A., Cecere, S.C., De Cecio, R., Normanno, N., Colombo, N., Lorusso, D., Russo, D., Nardelli, C., D’Incalci, M., Llop-Guevara, A., Pisano, C., Baldassarre, G., Mezzanzanica, D., Artioli, G., Setaro, M., Tasca, G., Roma, C., Campanini, N., Cinieri, S., Sergi, A., Musolino, A., Perrone, F., Chiodini, P., Marchini, S., Pignata, S.

Source: In ESMO Open October 2022 7(5)

Photon-based High-dose Single-fraction Radiosurgery, an Effective Treatment Modality for Large and Posterior Uveal Melanoma

Authors: Laliscia, C., Genovesi-Ebert, F., Perrone, F., Guido, F., Cresti, F., Fuentes, T., Coccia, N., Mattioni, R., Morganti, R., Paiar, F.

Source: Anticancer research. 42(4):1965-1972

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN628877785&indx=1&recIds=ETOCRN628877785

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

Authors: Di Maio, M., Basch, E., Denis, F., Fallowfield, L.J., Ganz, P.A., Howell, D., Kowalski, C., Perrone, F., Stover, A.M., Sundaresan, P., Warrington, L., Zhang, L., Apostolidis, K., Freeman-Daily, J., Ripamonti, C.I., Santini, D.

Source: In Annals of Oncology September 2022 33(9):878-892

Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement

Authors: Beretta, G.D., Casolino, R., Corsi, D.C., Perrone, F., Di Maio, M., Cinieri, S., Gobber, G., Bellani, M., Petrini, F., Zocchi, M.T., Traclò, F., Zagonel, V.

Source: In ESMO Open August 2022 7(4)

Skip pattern approach toward the early access of innovative anticancer drugs

Authors: Apolone, G., Ardizzoni, A., Biondi, A., Bortolami, A., Cardone, C., Ciniselli, C.M., Conte, P., Crippa, C., de Braud, F., Duca, M., Gori, S., Gritti, G., Inno, A., Luksch, R., Lussana, F., Maio, M., Pasello, G., Perrone, F., Rambaldi, A., Rossi, G., Signorelli, D., Soverini, G., Valente, M., Verderio, P., Buzzetti, G.

Source: In ESMO Open August 2021 6(4)

COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?

Authors: Silvestris, N., Di Maio, M., Russo, A., Chiari, R., De Giorgi, U., Del Mastro, L., Giuffrida, D., La Verde, N., Perrone, F., Tucci, M., Beretta, G.D., Cinieri, S.

Source: In ESMO Open April 2021 6(2)

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial

Authors: Pignata, S, Lorusso, D, Joly, F, Gallo, C, Colombo, N, Sessa, C, Bamias, A, Salutari, V, Selle, F, Frezzini, S, De Giorgi, U, Pautier, P, Bologna, A, Orditura, M, Dubot, C, Gadducci, A, Mammoliti, S, Ray-Coquard, I, Zafarana, E, Breda, E, Favier, L, Ardizzoia, A, Cinieri, S, Largillier, R, Sambataro, D, Guardiola, E, Lauria, R, Pisano, C, Raspagliesi, F, Scambia, G, Daniele, G, Perrone, F, Pignata, Sandro ^*, Lorusso, Domenica, Joly, Florence, Gallo, Ciro, Colombo, Nicoletta, Sessa, Cristiana, Bamias, Aristotelis, Salutari, Vanda, Selle, Frédèric, Frezzini, Simona, De Giorgi, Ugo, Pautier, Patricia, Bologna, Alessandra, Orditura, Michele, Dubot, Coraline, Gadducci, Angiolo, Mammoliti, Serafina, Ray-Coquard, Isabelle, Zafarana, Elena, Breda, Enrico, Favier, Laure, Ardizzoia, Antonio, Cinieri, Saverio, Largillier, Rémy, Sambataro, Daniela, Guardiola, Emmanuel, Lauria, Rossella, Pisano, Carmela, Raspagliesi, Francesco, Scambia, Giovanni, Daniele, Gennaro, Perrone, Francesco

Source: In The Lancet Oncology February 2021 22(2):267-276